TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: mean post-filter activated clotting time (ACT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Antitumor activity of D-1553
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Fall recovery performance (frequency)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fall recovery performance (movement quality)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient's self-reported psychometric outcomes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of days required to improve clinical symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of WHO ordinal scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The EQ-5D-5L Quality of Life Measure
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of days required for respiratory rate to return to normal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Frequency of biliary complications
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of pancreatic complications
Endpoint domain: Adverse events/effects
Primary endpoint: Prevalence of Type 2 Diabetes Mellitus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Prevalence of Intermediate Hyperglycemia (IHG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 2-year cumulative incidence of Type 2 Diabetes Mellitus
Endpoint domain: Mortality/survival
Primary endpoint: 1-back test accuracy (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1-back test reaction time (ms)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Colour Word Stroop test accuracy (congruent) (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Forced expiratory volume (FEV1) trough value changed from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Forced vital capacity (FVC) changes compared to baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: The change in chronic obstructive pulmonary disease (CAT) score from baseline
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Renal futility
Endpoint domain: Mortality/survival
Primary endpoint: DASH Scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Shoulder pain at rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ASEC0-t
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Corneal abrasion frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve below baseline MAP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in serum iron
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in ferritin iron
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in iron binding capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Occurrence of Opioid-induced hyperalgesia (OIH)
Endpoint domain: Adverse events/effects
Primary endpoint: Modified Rankin Scale (MRS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Barthel Activity Daily Living Index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: EuroQol Five Dimensions Questionnaire (EQ-5D)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Quadriceps Isometric Muscle Strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Duration of severe Oral Mucositis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Initiation of formal depression treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Progression Free Survival while Receiving ILDR combined Therapy (PFS2)
Endpoint domain: Mortality/survival
Primary endpoint: skeletal muscle fat oxidation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: hope level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: psychological wellbeing level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: social adjustment level
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Diagnostic performance of radiomic model
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Labor Agentry Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Performance of the Labcorp Preeclampsia Screen assay
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Percentage of Patients With Moderate/Severe Bazaz Classification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Patients With Severe Dysphagia Based on the Eating Assessment Tool (EAT-10)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC-ROC for Prediction of Parameters of Early Warning Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC-PRC for Prediction of Parameters of Early Warning Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: F1-Score for Prediction of Parameters of Early Warning Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Confusion Matrix for Prediction of Parameters of Early Warning Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of ICP elevations greater than 22 mmHg for greater than 5 minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean ICP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in physical performance: 6-minute walk test (6MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Logical Memory
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Free and Cued Selective Reminding Test (FCRT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Everyday Function
Endpoint domain: Life impact
Endpoint subdomain: Functional functioning
Primary endpoint: Safety of a health coaching intervention
Endpoint domain: Adverse events/effects
Primary endpoint: Change in fractional excretion of urea percentage in urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Prevalence of Postoperative Delirium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: serum bile acid profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Social Response Scale (SRS) Scores
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: The World Health Organization Quality of Life Brief Scale scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number and types of haptic glove malfunctions
Endpoint domain: Adverse events/effects
Primary endpoint: Number of medical complications > CD2a 30 days after surgery
Endpoint domain: Adverse events/effects
Primary endpoint: Stimulation current difference between adductor pollucis and dorsal interosseus muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stimulation threshold in hand supination and pronation postures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in disruptive behavior
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Mayo Bloating Questionnaire (MBQ) score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Overall Complete Remission (OCR) Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Telomeres length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in LA function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Evaluation of trueness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Kujala Patellofemoral Pain Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Navicular Droop Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bruininks-Oseretsky Motor Proficiency Test- 2 Short Form (BOT-2SF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pinch Grip Force
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: effectiveness with LBB pacing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of adverse events in patient with LBB pacing
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of septal perforation
Endpoint domain: Adverse events/effects
Primary endpoint: Positive pressure ventilation after delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of Solicited Systemic Treatment-Related Reactogenicity AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Serious AEs
Endpoint domain: Adverse events/effects
Primary endpoint: PPA
Endpoint domain: Physiological/clinical
Primary endpoint: NPA
Endpoint domain: Physiological/clinical
Primary endpoint: Change in KCCQ Overall Summary score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of aggressive or chronic periodontitis patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of leakage episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in standardized uptake value ratio (SUVR) on FBB-PET
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of mean hemoglobin compared to baseline during fixed treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change of mean hemoglobin during dose adjustment period
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: clinical impact of molecular urinary assay
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Comprehensibility regarding iDA content
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Usability regarding iDA format
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Feasibility regarding iDA format
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change From Baseline in Serum Phosporus Over Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change From Baseline in Serum Alkaline Phosphatase (ALP) Over Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change of Navy Plaque Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of Digitally Measured Interdental Plaque Area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of Detecting Solid Organ Injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of Detecting Solid Organ Injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Enrolled Participants With Successful Exams
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Occurrence of (serious) adverse device effects
Endpoint domain: Adverse events/effects
Primary endpoint: central sensitization measured by Patient Pain Drawing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: central sensitization measured by conditioned pain modulation using an algometer and a occlusion cuff
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: area under the concentration-time curve from the time of dosing to time t (AUC0-t)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: area under the concentration-time curve from time 0 to infinity (AUC0-∞)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiographical assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Communication Participation Person Centered Goals
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: oxygenization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mitochondrial respiration efficiency of PBMCs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Clinical symptoms of NF1 patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum LDL cholesterol concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in length-for-age Z-score (LAZ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in weight-for-age Z-score (WAZ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in head circumference-for-age Z-score (HCZ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in ASQ- Socio-Emotional (ASQ-SE) score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in ASQ Communication score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Changes in ASQ Gross Motor score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Minimum residual disease (MRD) rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relationship quality between caregivers and residents from residents' perspective
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Relationship quality between caregivers and residents from caregivers' perspective
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rate of change in low attenuation plaque volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in time trial test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number and severity of Dose Limiting Toxicities (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Serum Potassium Concentration During First Treatment Period
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Serum Potassium Concentration During Second Treatment Period
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Central (aortic) pulse pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Geometric mean titer (GMT) ratio for RSV A and RSV B serum neutralizing titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Adherence rates to tDCS and exercise therapy
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Transient changes in adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of vital sign abnormalities e.g. Systolic and Diastolic BP, Pulse rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Fidelity to the intervention model
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Relative-reported outcome
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clinician outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Objective Sleep Patterns
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Level of pain on pain scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cancer screening rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: neurofilament levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: miostatin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hammesrmith Functional motor Scale expanded
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in neutrophils/mL in nasal lavage fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in intervention feasibility and acceptability as assessed by recruitment/enrolment/dropout metrics
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in intervention feasibility and acceptability as assessed by the Intervention Engagement Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Intervention feasibility and acceptability as informed by focus groups
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: number of episodes of nocturnal bruxism
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle Na+ content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Detection Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of ExactVu
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Adaptive Cognitive Evaluation (ACE) Battery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subluxation of thumb carpometacarpal joint
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Movement Imagery Questionnaire-3
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Vividness of Motion Imagery Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Mean Alpha-Fetoprotein (AFP) Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with CAT (≥10, <10)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes of the immunogenicity against Omicron strain at Day 14
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Safety and tolerability of PHH-1V as a booster dose
Endpoint domain: Adverse events/effects
Primary endpoint: Sagittal cervical curve angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Deep flexors muscle endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance characteristics of FET PET
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post Operative Cognitive Dysfunction
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Mean nerve action potential amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Perceived Chemotherapy Induced Peripheral Neuropathy symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: pw-doppler wall motion analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: diastolic strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: SGM Related Stigma
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: HIV Testing Behaviors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Analog Scales scores for postoperative pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of Low Anterior Resection Syndrome (LARS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Changes in anxiety disorder
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Asthma Exacerbation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hospitalization for asthma
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Average duration of smartphone screen time
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: change in pulsatility index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Itraconazole blood levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in the SPARCC MRI inflammation score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change from baseline in 6 min-walk test distance at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in Glittre test at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in sit and stand test at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in Post-Covid Functional Scale at 12 weeks
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning